Sanli, Deniz Esin TekcanAltundag, AytugKandemirli, Sedat GirayYildirim, DuzgunSanli, Ahmet NecatiSaatci, OzlemKirisoglu, Ceyda ErelDikensoy, OnerMurrja, EdvinYesil, AtakanBastan, SerdarKarsidag, TamerAkinci, Ibrahim OzkanOzkok, SezenYilmaz, ErenTuzuner, FilizKilercik, MeltemLjama, Taner2023-02-212023-02-212021-01-0110.1016/j.amjoto.2020.102796https://hdl.handle.net/11443/2576http://dx.doi.org/10.1016/j.amjoto.2020.102796Background: An association between IL-6 levels and cytokine storm syndrome in COVID-19 patients has been suggested. Cases with higher IL-6 levels have more rapid progression and a higher complication rate. On the other hand, COVID-19 cases with anosmia have a milder course of the disease. Objective: We aimed to investigate whether there is a relationship between serum IL-6 levels and presence of anosmia in COVID-19 patients. Methods: Patients with a confirmed diagnosis of COVID-19 based on laboratory (PCR) were stratified into two groups based on presence of olfactory dysfunction (OD). In all cases with and without anosmiapsychophysical test (Sniffin' Sticks test) and a survey on olfactory symptoms were obtained. Threshold (t) - discrimination (d) - identification (i), and total (TDI) scores reflecting olfactory function were calculated. Clinical symptoms, serum IL-6 levels, other laboratory parameters, and chest computed tomography (CT) findings were recorded. Results: A total of 59 patients were included, comprising 23 patients with anosmia and 36 patients without OD based on TDI scores. Patients with anosmia (41.39 +/- 15.04) were significantly younger compared to cases without anosmia (52.19 +/- 18.50). There was no significant difference between the groups in terms of comorbidities, smoking history, and symptoms including nasal congestion and rhinorrhea. Although serum IL-6 levels of all patients were above normal values (7 pg/mL), patients with anosmia had significantly lower serum IL-6 levels (16.72 +/- 14.28 pg/mL) compared to patients without OD (60.95 +/- 89.33 pg/mL) (p = 0.026). Conclusion: Patients with COVID-19 related anosmia tend to have significantly lower serum levels of IL-6 compared to patients without OD, and the lower IL-6 levels is related to milder course of the disease. With the effect of low cytokine storm and IL-6 level, it may be said that anosmic cases have a milder disease in COVID-19.COVID-19AnosmiaIL-6PrognosisMild diseaseCytokine stormOlfactory dysfunctionSniffin' Sticks testThreshold discrimination identificationComputed tomographyArticleWOS:000600420000015